Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/BCAX/Gross margin

Bicara Therapeutics Inc. (BCAX) Gross margin

Bicara Therapeutics Inc. (BCAX) gross margin by fiscal year — reported gross profit divided by reported revenue.

No annual history for this metric yet

The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.

← Back to BCAX

Source: SEC XBRL filings · For reference only · Not investment advice

More BCAX financial trends

BCAX RevenueBCAX Net incomeBCAX Net marginBCAX Gross profitBCAX Operating incomeBCAX Operating marginBCAX Operating cash flowBCAX Free cash flowBCAX Capital expendituresBCAX Return on equityBCAX Stock buybacksBCAX Dividends paidBCAX Total assetsBCAX Total liabilitiesBCAX Shareholders’ equityBCAX overview →